Krystal Biotech (KRYS) Enterprise Value (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.53% |
| Dec 31, 2025 | -13.23% |
| Sep 30, 2025 | -7.20% |
| Jun 30, 2025 | -10.56% |
| Mar 31, 2025 | -3.23% |
| Dec 31, 2024 | -1.56% |
| Sep 30, 2024 | -5.13% |
| Jun 30, 2024 | -3.97% |
| Mar 31, 2024 | -1.14% |
| Dec 31, 2023 | 5.32% |
| Sep 30, 2023 | -17.71% |
| Jun 30, 2023 | -36.28% |
| Mar 31, 2023 | 7.59% |
| Dec 31, 2022 | 3.87% |
| Sep 30, 2022 | 7.32% |
| Jun 30, 2022 | 2.09% |
| Mar 31, 2022 | 0.79% |
| Dec 31, 2021 | -27.69% |
| Sep 30, 2021 | 6.70% |
| Jun 30, 2021 | 8.85% |
| Mar 31, 2021 | -48.72% |
| Dec 31, 2020 | 5.27% |
| Mar 31, 2020 | 3.60% |
| Dec 31, 2019 | 4.69% |
| Sep 30, 2019 | -3.96% |
| Jun 30, 2019 | -83.31% |
| Mar 31, 2019 | 4.59% |
| Dec 31, 2018 | -113.72% |
| Sep 30, 2018 | -15.06% |
| Jun 30, 2018 | 3.76% |
| Mar 31, 2018 | 4.76% |
| Dec 31, 2017 | 5.67% |
| Sep 30, 2017 | -1,394.31% |
| Jun 30, 2017 | -82.94% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | -383.17% |